At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 100 enrolled
Drug / intervention
OPC-12759 Ophthalmic solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety Study of OPC-12759 Ophthalmic Solution in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating OPC-12759 Ophthalmic solution and OPC-12759 Ophthalmic suspension for Dry Eye Syndromes. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the safety of OPC-12759 ophthalmic solution in healthy subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesJapan
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedNov 2011
Primary CompletionDec 2011
Study CompletionFeb 2012
TodayJul 2026
First PostedNov 11, 2011
Enrollment StartNov 1, 2011
Primary CompletionDec 1, 2011
Study CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.6 years ago
Interventions
OPC-12759 Ophthalmic solutiondrug
2％ OPC-12759 Ophthalmic solution
OPC-12759 Ophthalmic suspensiondrug
2％ OPC-12759 Ophthalmic suspension